Using the Aβ-injected zebrafish and transgenic mouse (APdE9 mice) models of AD, they further experimentally found that FMNL2 is upregulated and expressed in astrocytes with Aβ burden and loosens gliovascular interactions to promote Aβ clearance in brains. Here, FMNL2 is linked to Alzheimer disease.